What complications can arise from prolonged propofol infusion (greater than 48 hours or >4 mg/kg/h)?

Complications of Prolonged Propofol Infusion

The most critical life-threatening complication of prolonged propofol infusion is Propofol Infusion Syndrome (PRIS), a potentially fatal condition with up to 33% mortality that requires immediate recognition and discontinuation of propofol. 1

Propofol Infusion Syndrome (PRIS)

Clinical Presentation

PRIS manifests with a constellation of severe metabolic and organ system derangements 1:

Core Features:

• Metabolic acidosis (worsening, often severe)
• Cardiac manifestations: Hypotension with increasing vasopressor requirements, arrhythmias, cardiac failure
• Hyperkalemia
• Hypertriglyceridemia (though may be absent in >95% of cases) 2

Additional Features:

• Acute kidney injury
• Rhabdomyolysis (with elevated creatine kinase)
• Hepatomegaly and liver dysfunction
• ECG changes including Brugada-like coved ST segment elevation 3

Risk Factors and Dosing Thresholds

PRIS typically occurs with:

• Prolonged infusions >48 hours at doses >70 μg/kg/min (>4 mg/kg/h) 1
• However, PRIS can occur at lower doses and shorter durations 1, 2

Major risk factors include 1:

• Decreased oxygen delivery to tissues
• Serious neurological injury and/or sepsis
• High doses of vasoconstrictors, steroids, or inotropes
• Young age (particularly pediatric patients)
• Traumatic brain injury 2

Critical caveat: Recent evidence shows PRIS developing in older patients at lower propofol doses than historically reported, with some typical features (hypertriglyceridemia, fever, hepatomegaly) frequently absent 2. Cases have been reported with infusions <4 mg/kg/h and even after short-term exposure (<48 hours) 2, 4, 5.

Pathophysiology

The syndrome results from 1:

• Mitochondrial dysfunction
• Impaired fatty acid oxidation
• Diversion of carbohydrate metabolism to fat substrates
• Accumulation of propofol metabolites

Management

Immediate action required:

1. Discontinue propofol immediately upon suspicion 1
2. Switch to alternative sedation (dexmedetomidine or benzodiazepines)
3. Provide supportive care
4. Consider renal replacement therapy or extracorporeal membrane oxygenation in severe cases 6

Important: Mortality can occur even after discontinuing the infusion, and the variable presentation makes detection difficult 1.

Other Complications of Prolonged Propofol Use

Pharmacokinetic Issues

Prolonged emergence from sedation occurs due to 1:

• Saturation of peripheral tissues with long-term administration
• Accumulation in fat and muscle stores
• Slower redistribution back to plasma after extended infusions (>10 days)

After prolonged infusions, reduce the infusion rate by up to 50% to maintain constant plasma levels and prevent excessive drug accumulation 3.

Cardiovascular Effects

• Dose-dependent hypotension from systemic vasodilation 1
• Respiratory depression 1
• More pronounced when combined with opioids or other sedatives
• Higher risk in patients with baseline cardiovascular instability or respiratory insufficiency 1

Metabolic and Lipid-Related Complications

• Hypertriglyceridemia (propofol is in 10% lipid emulsion providing 1.1 kcal/mL) 1
• Acute pancreatitis 1
• Monitor triglyceride levels during prolonged infusions

Neurological Effects

• Myoclonus 1
• In patients with increased intracranial pressure, propofol can decrease cerebral perfusion pressure if mean arterial pressure drops significantly 3

Allergic Reactions

Propofol contains 1:

• Egg lecithin and soybean oil (avoid in egg/soy allergies)
• Sulfite preservatives in some generic formulations (avoid in sulfite allergies)

Infection Risk

Propofol supports microbial growth 3:

• Strict aseptic technique required
• Replace tubing every 6-12 hours per manufacturer recommendations 7
• Never access vials more than once or use on multiple patients 3
• Discard within required time limits

Monitoring During Prolonged Infusions

Essential surveillance includes:

• Daily assessment of sedation level and dose titration 1
• Arterial blood gases for metabolic acidosis
• Serum triglycerides
• Creatine kinase levels
• Renal function
• Liver function tests
• ECG monitoring for arrhythmias or Brugada-like changes
• Hemodynamic parameters

Red flags requiring immediate propofol discontinuation:

• Worsening metabolic acidosis despite treatment
• Increasing propofol requirements to maintain constant sedation
• New onset bradycardia resistant to treatment
• Rising creatine kinase or evidence of rhabdomyolysis
• Green urine (early sign) 5

Special Populations

Elderly patients: Require lower doses due to decreased volume of distribution and clearance; higher peak concentrations increase risk of cardiorespiratory depression 3

Pediatric patients: Higher risk of PRIS; FDA warns about neurotoxicity with prolonged exposure (>3 hours) in developing brains 3

ICU sedation: FDA approval is only for <24 hours at ≤0.7 μg/kg/h, though off-label use up to 28 days has been reported 1. The incidence of PRIS in ICU patients is approximately 1% 1.